Clinical trials in Greensboro, NC

47 recruiting studies have a site in or near Greensboro, NC, North Carolina.

Top conditions here

All conditions

Showing 40 of 47 studies

RecruitingPhase 2NCT07752979

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Sponsor: AbbVie

Greensboro, NC · Monroe, NC · Morehead City, NC · +56 more sites

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Asheboro, NC · +1147 more sites

RecruitingPhase 3NCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Greensboro, NC · Matthews, NC · Morehead City, NC · +145 more sites

RecruitingPhase 3NCT07674654

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Charlotte, NC · Greensboro, NC · +110 more sites

RecruitingPhase 3NCT07177352

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Sponsor: Hoffmann-La Roche

Greensboro, NC · +67 more sites

RecruitingPhase 4NCT07609914

A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

Sponsor: Pfizer

Greensboro, NC · +20 more sites

RecruitingPhase 3NCT06307652

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Sponsor: AstraZeneca

Asheville, NC · Chapel Hill, NC · Charlotte, NC · +163 more sites

RecruitingPhase 3NCT06736574

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Sponsor: Cytokinetics

Cary, NC · Chapel Hill, NC · Durham, NC · +85 more sites

RecruitingNot applicableNCT06898515

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Sponsor: Reprieve Cardiovascular, Inc

Durham, NC · Greensboro, NC · Winston-Salem, NC · +32 more sites

RecruitingPhase 3NCT07595549

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Sponsor: Pfizer

Greensboro, NC · Wilmington, NC · +32 more sites

RecruitingPhase 3NCT07667803

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Sponsor: AstraZeneca

Greensboro, NC · Raleigh, NC · Rocky Mount, NC · +53 more sites

RecruitingPhase 2NCT07795814

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

Sponsor: Edgewise Therapeutics, Inc.

Greensboro, NC · +27 more sites

RecruitingPhase 3NCT06810505

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Sponsor: AbbVie

Greensboro, NC · +31 more sites

RecruitingPhase 3NCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Sponsor: Amgen

Charlotte, NC · Durham, NC · Greensboro, NC · +137 more sites

RecruitingPhase 2NCT07589608

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Sponsor: Eli Lilly and Company

Greensboro, NC · Monroe, NC · Morehead City, NC · +37 more sites

RecruitingPhase 3NCT07794579

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Sponsor: Eli Lilly and Company

Greensboro, NC · Monroe, NC · Morehead City, NC · +77 more sites

RecruitingPhase 2NCT06143956

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Sponsor: Eli Lilly and Company

Greensboro, NC · Monroe, NC · Morehead City, NC · +47 more sites

RecruitingPhase 2NCT07668388

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Sponsor: Novo Nordisk A/S

Greensboro, NC · Wilmington, NC · +23 more sites

RecruitingPhase 3NCT05711394

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Sponsor: AbbVie

Greensboro, NC · +41 more sites

RecruitingPhase 3NCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Fayetteville, NC · Greensboro, NC · Greenville, NC · +232 more sites

RecruitingPhase 3NCT07564414

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Sponsor: Novo Nordisk A/S

Greensboro, NC · Greenville, NC · Morehead City, NC · +96 more sites

RecruitingPhase 3NCT07668414

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Sponsor: Novo Nordisk A/S

Greensboro, NC · Statesville, NC · +43 more sites

RecruitingPhase 3NCT07761117

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Sponsor: AstraZeneca

Chapel Hill, NC · Durham, NC · Greensboro, NC · +117 more sites

RecruitingPhase 3NCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Sponsor: Pfizer

Charlotte, NC · Greensboro, NC · +166 more sites

RecruitingPhase 3NCT04743141

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Sponsor: Pfizer

Charlotte, NC · Greensboro, NC · +113 more sites

RecruitingPhase 3NCT07339423

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Sponsor: Novo Nordisk A/S

Chapel Hill, NC · Greensboro, NC · Wilmington, NC · +19 more sites

RecruitingPhase 3NCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Greensboro, NC · Matthews, NC · Morehead City, NC · +99 more sites

RecruitingPhase 3NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Sponsor: Eli Lilly and Company

Chapel Hill, NC · Greensboro, NC · Morehead City, NC · +56 more sites

RecruitingPhase 3NCT07784270

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Sponsor: AstraZeneca

Greensboro, NC · Monroe, NC · +52 more sites

RecruitingPhase 3NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Sponsor: Stemline Therapeutics, Inc.

Durham, NC · Fayetteville, NC · Greensboro, NC · +173 more sites

RecruitingPhase 2NCT07415954

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Sponsor: Novo Nordisk A/S

Greensboro, NC · Statesville, NC · +21 more sites

RecruitingPhase 3NCT07745504

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Sponsor: Novo Nordisk A/S

Greensboro, NC · Wilmington, NC · +9 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Albemarle, NC · Asheboro, NC · +1223 more sites

RecruitingPhase 2NCT07333183

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Sponsor: Pulmovant, Inc.

Greensboro, NC · +12 more sites

RecruitingPhase not listedNCT06388421

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: United Therapeutics

Chapel Hill, NC · Durham, NC · Greensboro, NC · +67 more sites

RecruitingPhase 3NCT07645924

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Charlotte, NC · Greensboro, NC · +110 more sites

RecruitingNot applicableNCT05650541

Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure

Sponsor: Analog Device, Inc.

Greensboro, NC · +6 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Albemarle, NC · Asheboro, NC · +825 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Albemarle, NC · Asheboro, NC · Burlington, NC · +378 more sites

RecruitingPhase not listedNCT06699056

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Sponsor: Peerbridge Health, Inc

Greensboro, NC · +7 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.